Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Nature Communications|November 29, 2025
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancerJingxin Fu, Adrienne G Waks, Erica Pimenta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast CancerAdrienne G Waks, Dewey Kim, Esha Jain, et al.
NPJ Breast Cancer|February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
JCO Precision Oncology|June 26, 2023
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Cancer Discovery|May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with PertuzumabOtto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective StudyInes Vaz-Luis, Romualdo Barroso-Sousa, Antonio Di Meglio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2026
Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6Anne Fassl, Miriam Palacios Espinoza, Deborah Butter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
The Journal of Clinical Investigation|February 1, 2024
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trialZheqi Li, Otto Metzger Filho, Giuseppe Viale, et al.
Pageof 5